Journal of the Royal Society of Medicine
-
To offer a quantitative risk-benefit analysis of two doses of SARS-CoV-2 vaccination among adolescents in England. ⋯ Given the current (as at 15 September 2021) high case rates (680/100,000 population/week in 10-19 year olds) in England, our findings support vaccination of adolescents against SARS-CoV2.